VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.28
Tradestie Score
31
Market Cap
$108.92M
Revenue Growth
5.0%
Analyst Upside
+255.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.92
|
$154.27M | - | 68 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.73
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.80
|
$110.20M | - | 61 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.86
|
$84.52M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.68
|
$67.94M | - | 45 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$30.57
|
$62.81M | - | 57 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$0.59
|
$46.20M | - | 46 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$1.98
|
$34.77M | - | 41 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$2.24
|
$4.78M | - | 58 | Compare |
More VTGN Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry